Cytosorbents (CTSO) Free Cash Flow (2010 - 2026)
Cytosorbents' (CTSO) quarterly Free Cash Flow came in at -$1.2 million in Q1 2026, up 66.18% YoY from -$705876.1 in Q1 2025, and up 76.22% on a QoQ basis from -$4.9 million in Q4 2025.
Cytosorbents (CTSO) Free Cash Flow (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Free Cash Flow data on file, last reported at -$1.2 million in Q1 2026.
- Quarterly Free Cash Flow rose 66.18% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.2 million (up 21.36% YoY) and the FY2025 annual result came in at -$12.5 million, up 13.13% from the prior year.
- Free Cash Flow rose to -$1.2 million in Q1 2026, from -$4.9 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $173636.0 in Q4 2022 to a low of -$12.4 million in Q3 2022.
- A 5-year average of -$4.6 million and a median of -$4.8 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow surged 101.9% — and 2023, when it sank 4100.05%.
- Tracing CTSO's Free Cash Flow over 5 years: stood at $173636.0 in 2022, then slumped by 4100.05% to -$6.9 million in 2023, then soared by 69.28% to -$2.1 million in 2024, then slumped by 131.16% to -$4.9 million in 2025, then surged by 76.22% to -$1.2 million in 2026.
- The last three Free Cash Flow figures came in at -$1.2 million (Q1 2026), -$4.9 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -597,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -597,000.00 |
| Jun 30, 2026 | -597,000.00 |
| Mar 31, 2026 | -1.17 Mn |
| Mar 31, 2026 | -1.17 Mn |
| Dec 31, 2025 | -4.93 Mn |
| Dec 31, 2025 | -4.93 Mn |
| Sep 30, 2025 | -2.59 Mn |
| Sep 30, 2025 | -2.59 Mn |
| Jun 30, 2025 | -1.55 Mn |
| Jun 30, 2025 | -1.55 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | -2.62 Mn |
| Sep 30, 2024 | -2.62 Mn |
| Jun 30, 2024 | -4.81 Mn |
| Jun 30, 2024 | -4.81 Mn |
| Mar 31, 2024 | -4.87 Mn |
| Mar 31, 2024 | -4.87 Mn |